Second Hospital of Shanxi Medical University
In research, Second Hospital of Shanxi Medical University stands highest in Medicine (#1,387 of 10,443 worldwide), Health Sciences (#1,776 of 11,982 worldwide) and Life Sciences (#1,634 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Rheumatology, Immunology and Cancer Research — Rheumatology is 16.8× its share of world research.
- World rank, 2022–2025
- #3,453 of 28,054 · #9,279 all time
- Rank in China
- #838 of 3,058
- Research works
- 2.2k ▲ 67% vs 2013–17
- Citations
- 17k 7.7 per fractional work
- Top-10% rate
- 19.6% record average 16.5%
- Open access
- 43% world 28%
What is Second Hospital of Shanxi Medical University known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,387 of 10,443 | 20.0% | 430 | #4020 | |
| Health SciencesDomain | #1,776 of 11,982 | 20.2% | 446 | #4993 | |
| Life SciencesDomain | #1,634 of 7,800 | 18.0% | 206 | #4447 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,054 of 3,579 | 17.0% | 134 | #5027 | |
| Molecular BiologySubfield | #1,564 of 2,175 | 18.2% | 83 | #3624 |
Each strip is that field’s whole ranked pool, with the notch where Second Hospital of Shanxi Medical University sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#4,020 #1,387
- Health Sciences#4,993 #1,776
- Life Sciences#4,447 #1,634
- Biochemistry, Genetics and Molecular Biology#5,027 #2,054
- Molecular Biology#3,624 #1,564
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Second Hospital of Shanxi Medical University specialise in?
Where its research is concentrated relative to its size: Rheumatology takes 16.8× the share of its output that it takes of world research.
- RheumatologySubfield · 54.7 works17×
- ImmunologySubfield · 37.6 works7.7×
- Cancer ResearchSubfield · 20.7 works6.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.7×. Every wedge is a field page.
- Immunology and Microbiology 5.7×
- Biochemistry, Genetics and Molecular Biology 3.5×
- Medicine 3.1×
- Pharmacology, Toxicology and Pharmaceutics 2.1×
- Neuroscience 1.8×
- Nursing 1.2×
- Dentistry 1.1×
- Materials Science 0.5×
- Veterinary 0.4×
- Health Professions 0.4×
- Chemistry 0.3×
- Psychology 0.2×
- Engineering 0.2×
- Environmental Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Mathematics 0.1×
- Decision Sciences 0.1×
- Energy 0.1×
- Arts and Humanities 0.0×
- Economics, Econometrics and Finance 0.0×
- Social Sciences 0.0×
- Physics and Astronomy 0.0×
Which keywords describe research at Second Hospital of Shanxi Medical University?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Epidemiology, Oxidative Stress, Autoantibodies, Tumor Microenvironment, Gene Expression and Cardiovascular Disease.
- Joint Inflammation
- Toll-like Receptors
- TGF-ß
- Rheumatoid Arthritis
- Angiogenesis
- Cell Death
- Prognostic Factors
- Cartilage
- Fibrosis
- Biogenesis
- Obesity
- Hypertrophy
- Matrix Metalloproteinases
- Regeneration
- Metabolic Syndrome
- Biomarkers
- Gene Expression
- Treatment
- Oxidative Stress
- Cancer
- Inflammation
- Epidemiology
- Cardiovascular Disease
- Autoantibodies
- Tumor Microenvironment
- Cytokines
- Immune Response
- Cardiovascular Risk
- Mesenchymal Stem Cells
- Metastasis
- Osteoarthritis
- Regulation
- Insulin Resistance
- Chondrocyte
- Inflammatory Diseases
- Atherosclerosis
- Epigenetic Regulation
- Regulatory T Cells
- Biological Therapy
- Disease-Modifying Antirheumatic Drugs
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation110▲ 7.4×75 topics
- Cancer69▲ 7.2×47 topics
- Epidemiology60▲ 2.1×94 topics
- Oxidative Stress43▲ 3.7×52 topics
- Cardiovascular Disease32▲ 4.1×33 topics
- Treatment28▲ 3.3×30 topics
- Autoantibodies27▲ 16×8 topics
- Gene Expression27▲ 6.3×13 topics
- Tumor Microenvironment26▲ 8.2×8 topics
- Biomarkers24▲ 4.9×16 topics
- Cytokines24▲ 12×7 topics
- Metabolic Syndrome23▲ 3.9×21 topics
- Immune Response21▲ 5.3×17 topics
- Regeneration20▲ 15×6 topics
- Cardiovascular Risk20▲ 8.9×9 topics
- Matrix Metalloproteinases19▲ 19×5 topics
- Mesenchymal Stem Cells19▲ 25×3 topics
- Hypertrophy18▲ 38×2 topics
- Metastasis17▲ 7.1×12 topics
- Obesity17▲ 3.1×19 topics
- Osteoarthritis17▲ 19×4 topics
- Biogenesis16▲ 13×3 topics
- Regulation16▲ 4.1×9 topics
- Fibrosis16▲ 12×8 topics
- Insulin Resistance16▲ 4.8×10 topics
- Cartilage15▲ 45×1 topic
- Chondrocyte15▲ 45×1 topic
- Prognostic Factors15▲ 4.8×11 topics
- Inflammatory Diseases15▲ 11×5 topics
- Cell Death14▲ 8.8×6 topics
- Atherosclerosis14▲ 7.1×11 topics
- Angiogenesis13▲ 5.6×14 topics
- Epigenetic Regulation13▲ 8.4×5 topics
- Rheumatoid Arthritis13▲ 19×4 topics
- Regulatory T Cells13▲ 16×4 topics
- TGF-ß13▲ 12×4 topics
- Biological Therapy11▲ 28×2 topics
- Toll-like Receptors11▲ 14×4 topics
- Disease-Modifying Antirheumatic Drugs11▲ 31×1 topic
- Joint Inflammation11▲ 31×1 topic
Which research topics does Second Hospital of Shanxi Medical University publish most on?
By volume in 2022–2025: Osteoarthritis Treatment and Mechanisms, Rheumatoid Arthritis Research and Therapies, Gut microbiota and health and Systemic Lupus Erythematosus Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Osteoarthritis Treatment and Mechanisms Rheumatology 15 works
- 2 Rheumatoid Arthritis Research and Therapies Rheumatology 11 works
- 3 Gut microbiota and health Molecular Biology 9 works
- 4 Systemic Lupus Erythematosus Research Rheumatology 9 works
- 5 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 8 works
- 6 Spondyloarthritis Studies and Treatments Rheumatology 7 works
- 7 Cancer-related molecular mechanisms research Cancer Research 7 works
- 8 MicroRNA in disease regulation Cancer Research 7 works
- 9 Acute Myeloid Leukemia Research Hematology 6 works
- 10 Total Knee Arthroplasty Outcomes Surgery 6 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Second Hospital of Shanxi Medical University's research output changed?
Output in 2018–2022 was 67% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Taiyuan
- Taiyuan University of Technology
- Shanxi University
- North University of China
- Shanxi Medical University
- Taiyuan University of Science and Technology
- Institute of Coal Chemistry
- Shanxi University of Finance and Economics
- Taiyuan Normal University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.